Rokita; Steven E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rokita; Steven E..The latest application filed is for "dinuclear copper-based and compound and ligand for nucleic acid scission and anticancer treatment".

Company Profile

0.7.4

Rokita; Steven E. - Sliver Spring MD
Rokita; Steven E. - Silver Spring MD
Rokita, Steven E. - Kennethd D. MD
Rokita; Steven E. - Port Jefferson NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment Grant 7,390,832 - Rokita , et al. June 24, 2	2008-06-24
Nickel-based reagents for detecting DNA and DNA-protein contacts Grant 7,371,579 - Rokita , et al. May 13, 2	2008-05-13
Dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment Grant 7,365,060 - Rokita , et al. April 29, 2	2008-04-29
Dinuclear copper-based and compound and ligand for nucleic acid scission and anticancer treatment App 20050148662 - Rokita, Steven E. ; et al.	2005-07-07
Dinuclear cooper-based compounds and ligamd for nucleic acid scission and anticancer treatment App 20050090479 - Rokita, Steven E. ; et al.	2005-04-28
Trinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment App 20050026897 - Rokita, Steven E. ; et al.	2005-02-03
Recognition-driven alkylation of biopolymers App 20040072212 - Rokita, Steven E. ; et al.	2004-04-15
Ion triggered alkylation of biological targets by silyloxy aromatic agents Grant 5,831,073 - Rokita , et al. November 3, 1	1998-11-03
Modification of DNA and oligonucleotides using metal complexes of polyaza ligands Grant 5,504,075 - Burrows , et al. April 2, 1	1996-04-02
Nucleic acids labeled with naphthoquinone probe Grant 5,292,873 - Rokita , et al. March 8, 1	1994-03-08
Modification of DNA and oligonucleotides using metal complexes of polyaza ligands Grant 5,272,056 - Burrows , et al. December 21, 1	1993-12-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.